Recent content

Toward a Global Moratorium on Plant Monopolies

UN FAO, CGIAR Move to Defend Farmers' Rights, Crop Germplasm; Call for Plant "Patent" Moratorium on CG Seeds

The UN Food and Agriculture Organization (FAO) and the Consultative Group on International Agricultural Research (CGIAR) are moving quickly, and in concert to address abuses of their trust agreements covering several hundred thousand invaluable crop seed accessions, according to the Rural Advancement Foundation International (RAFI).

Aussies Pirate

International Confusion, Anger Greet Australian Kleptomania of Farmers' Plant Varieties from other Countries.

The agricultural departments of at least four Australian state governments, as well as a bevy of other national public and private research institutes, are routinely pirating the indigenous knowledge of farming communities and international research institutes around the world, according to the Canada-based Rural Advancement Foundation International (RAFI) - a rural advocacy organization with twenty years experience in the field. Accusing the Aussie agencies of making cowboy claims' on farmer-bred plant varieties from Brazil to India, RAFI's Executive Director, Pat Roy Mooney, says that several dozen plant 'patent' claims listed by Canberra's Plant Breeder's Rights Office are 'a clear rip-off of the genius of others. In most of these cases, the Australians appear to have done nothing more than select and multiply somebody else's seed and then slap a PBR (plant patent) monopoly on them,' Mooney insists.

International Research Centre (ICARDA) Breaks Trust

Allows Australians to "Patent" Plants Supposedly Held in Trust for Farmers

The Syrian-based International Centre for Agricultural Research in Dry Areas (ICARDA) has fundamentally misinterpreted its authority" with respect to crop germplasm it holds in trust on behalf of the United Nations, according to the Rural Advancement Foundation International (RAFI). In a letter sent to RAFI's Executive Director, Pat Mooney, on January 26th, ICARDA's Director-General, Prof. Dr Adel El-Beltagy, admitted that the Centre had willingly allowed a number of Australian institutes to apply for Plant Breeder's Rights (a form of plant patent) on varieties the Centre holds under a trusteeship agreement with the UN Food and Agriculture Organization (FAO) in Rome.

Australians Abandon 2 Plant Patent "Claims"

But many questions remain ... and the fate of 26 other claims are in doubt

Australian crop development agencies have been forced to abandon their claims on two chickpea varieties they admit were obtained from an international public research institute based in India (see RAFI's release of 6 January). In a blunt message sent January 8th, the institute, the International Crops Research Institute for the Semi-Arid Tropics (ICRISAT) - acting on information from RAFI - demanded that the claims for Australian Plant Breeders' Rights (a patent-like intellectual property regime for crop varieties) be dropped. On January 16th, the two Australian institutes - Agriculture WA and CLIMA - said that the claims had been abandoned.

Recent Australian Claims to Indian and Iranian Chickpeas Countered by NGOs and ICRISAT

Or, how to "invent" a chickpea without really trying

The Australian seed industry has applied for plant breeder's rights (PBR) on two chickpea varieties taken from ICRISAT (International Crops Research Institute for the Semi-Arid Tropics) - an internationally-funded public research centre based in Hyderabad, India. If granted, the Australians will give themselves a 20 year monopoly on the Asian chickpeas, which they propose to market in South Asia and the Middle East. Neither variety, however, is new to farmers. In fact, both are ICRISAT accessions originating in farmer's fields in Iran and India. It's blatant biopiracy," explains Farhad Mazhar of Bangladeshi organization UBINIG and the South Asian Network on Food, Ecology, and Culture, "Australia is privatizing seeds that belong to our farmers, and they plan to sell them back to us with their own self-authorized plant monopoly."

Confinamientos de la Razón: Monopolios Intelectuales

Material de Apoyo sobre Conocimiento Local, Biodiversidad y Propiedad Intelectual

Una introducción a los monopolios de la propiedad intelectual. Este folleto de 70 páginas, producido por el CIID (en inglés en 1996 y en español en 1997), está diseñado para servir como una herramienta de defensa para la sociedad civil y los formuladores de políticas, particularmente en relación a dos compromisos legales internacionales: El Convenio sobre Diversidad Biológica y los Aspectos de la Propiedad Intelectual Relacionados con el Comercio de la Organización Mundial de Comercio.

Human Nature - Agricultural Biodiversity and Farm-Based Food Security

An independent study prepared by RAFI, now ETC group, for the United Nations Food and Agriculture Organization

ETC group provides an in-depth review and analysis of plant genetic resources, livestock diversity, forest biodiversity, fish and aquatic life, soil and microbial biodiversity. The book emphasizes the need for farm-based food security and summarizes the emerging policy agenda for agricultural biodiversity. 90 pages.

Update: The Life Industry - 1997

The global enterprises that dominate commercial agriculture, food and health

In 1997, for the first time in history, global mergers and acquisitions topped 1 trillion dollars - almost 10 times the value of all takeovers at the outset of this decade. UNCTAD revealed that 79% of all foreign direct investment to the South is now in the form of corporate acquisitions and a parallel US government report advises that 40-45% of all manufacturing sales are between subsidiary and parent multinationals. 1 The multilateral agreement on investment (MAI) currently being negotiated by industrialized countries behind closed doors, if adopted, could be the final blow to national sovereignty and signal the de facto ascendancy of transnational enterprises to the political control of the world's economy. During 1997, the life industry was also active in consolidating its power over the world's biological resources...

*The world's top 10 agrochemical corporations accounted for 82% of the global agrochemical sales in 1996. Sales reached US $30.5 billion last year, up more than 15% since 1994.

*The top 10 seed corporations control approximately 40% of the commercial seed market, valued at approximately (US) $15 billion.

*The world pharmaceutical market is an estimated $251 billion; the top 10 enterprises control approximately 36% of the global market. The top 20 drug companies control 57%.

*By the end of 1997, the top 10 veterinary medicine corporations are expected to hold 63% of the total worldwide market.

Volume 4, #3 CGIAR Governance in 1997

Governance and the CG's Third Review - A Civil Society Report on International Agricultural Research

In 1997, the Consultative Group on Internatinal Agricultural Research (CGIAR) made notable progress in expanding the participation of the South and of women in their governance system. There is evidence that the trend that prevailed in the first half of the 1990's is reversing and that CG members and the Boards of Trustees of the 16 International Agricultural Research Centres (IARCs) are moving, albeit slowly, to achieve a better regional ration in their various levels of governance. Much of the credit for this shift goes to CGIAR's Chair.

Companies Step Up Efforts to Sample Remote Populations

Alliances and Financial Stakes Grow in Human DNA Prospecting

According to an article in the October 24th edition of Science magazine, In a new gold rush, genetics researchers are scouring odd corners of the world for families whose DNA is likely to carry interesting genes. They won't be freely sharing what they find, because their backing comes from companies like Sequana Therapeutics Inc. of La Jolla, California; Millennium Pharmaceuticals Inc. of Cambridge, Massachusetts; and Genset S.A. of Paris."

The reason why they won't share: The companies are looking to patent and profit from the DNA of remote populations. Just over a week after the Science report, on November 3, Arris Pharmaceuticals of California announced it would pay US $166 million in stock to take over Sequana, one of the highest profile human DNA prospecting companies. The merged company resulting from the Arris takeover will be called Axys Pharmaceuticals.1

Scientific Review Rejects the HGDP

NRC Signals Need For Ethical Strategy to Protect Diversity. HGDP Opponents Vindicated After Five Years of Controversy

A US National Research Council (NRC) report released October 21 has unambiguously rebuffed the controversy-plagued Human Genome Diversity Project (HGDP), a project that proposed to collect DNA samples from over 700 groups of people - mostly indigenous communities - from around the world.

Biopiracy Update 1997: The Inequitable Sharing of Benefits

HGDP Rejected

The life industry and US government are using bilateral bioprospecting agreements as their tool of choice to cheaply access genetic resources and undervalue farmers' resources and knowledge. These bilaterial agreements actually encourage inequities through patents, secrecy, and imbalanced negotiations that favour companies, not the true innovators and sustainable users of diversity, farmers and indigenous people.

Páginas

Suscribirse a Recent content